{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:24:42Z","timestamp":1793057082454,"version":"4.5.0"},"reference-count":273,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bcp.2023.115804","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:39:41Z","timestamp":1694752781000},"page":"115804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment"],"prefix":"10.1016","volume":"217","author":[{"given":"Jorge Humberto Lim\u00f3n","family":"Pacheco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-9126","authenticated-orcid":false,"given":"Guillermo","family":"Elizondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1016\/j.bcp.2023.115804_b0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41021-016-0071-7","article-title":"Estrogen- and stress-induced DNA damage in breast cancer and chemoprevention with dietary flavonoid","volume":"39","author":"Yasuda","year":"2017","journal-title":"Genes and Environment"},{"issue":"11","key":"10.1016\/j.bcp.2023.115804_b0020","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1021\/acs.chemrestox.7b00237","article-title":"Red clover aryl hydrocarbon receptor (AhR) and estrogen receptor (ER) agonists enhance genotoxic estrogen metabolism","volume":"30","author":"Dunlap","year":"2017","journal-title":"Chemical Research in Toxicology"},{"issue":"9","key":"10.1016\/j.bcp.2023.115804_b0025","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-04-0166","article-title":"Human CYP1B1 is regulated by estradiol via estrogen receptor","volume":"64","author":"Tsuchiya","year":"2004","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.18632\/oncotarget.1637","article-title":"Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR","volume":"5","author":"Litzenburger","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0035","doi-asserted-by":"crossref","first-page":"e0190619","DOI":"10.1371\/journal.pone.0190619","article-title":"High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism","volume":"13","author":"Vacher","year":"2018","journal-title":"PLoS One1"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2023.115804_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10911-015-9337-0","article-title":"Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy","volume":"20","author":"Arendt","year":"2015","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"key":"10.1016\/j.bcp.2023.115804_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: Overexpression and therapeutic implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Mol Biol Int"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0050","first-page":"59","article-title":"Molecular classification of breast carcinoma: from traditional","volume":"11","author":"Eliyatkin","year":"2015","journal-title":"Old-Fashioned Way to A New Age, and A New Way, J breast Health"},{"issue":"10286","key":"10.1016\/j.bcp.2023.115804_b0055","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bcp.2023.115804_b0060","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/annonc\/mdv022","article-title":"Genetics of breast cancer: a topic in evolution","volume":"26","author":"Shiovitz","year":"2015","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.bcp.2023.115804_b0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.genom.9.081307.164339","article-title":"Genetic predisposition to breast cancer: past, present, and future","volume":"9","author":"Turnbull","year":"2008","journal-title":"Annual Review of Genomics and Human Genetics"},{"issue":"20","key":"10.1016\/j.bcp.2023.115804_b0070","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bjsports-2021-105132","article-title":"Breast cancer association, physical activity, sedentary time and breast cancer risk: a mendelian randomisation study","volume":"56","author":"Dixon-Suen","year":"2022","journal-title":"British Journal of Sports Medicine"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0075","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/01635581.2023.2168022","article-title":"Healthy lifestyle and breast cancer risk in palestinian women: A Case-Control study","volume":"75","author":"El Sharif","year":"2023","journal-title":"Nutrition and Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12937-020-0520-9","article-title":"Association between healthy lifestyle score and breast cancer","volume":"19","author":"Ghosn","year":"2020","journal-title":"Nutrition Journal"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0085","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s12282-022-01374-w","article-title":"The associations of healthy lifestyle index with breast cancer incidence and mortality in a population-based study","volume":"29","author":"Li","year":"2022","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bcp.2023.115804_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2023.107446","article-title":"Children's study, maternal lifestyle and nutrient intakes during pregnancy and exclusive breastfeeding in relation to risk factors for breast cancer: the japan environment and children's Study","volume":"168","author":"Minami","year":"2023","journal-title":"Preventive Medicine"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/bcr628","article-title":"Oestrogen exposure and breast cancer risk","volume":"5","author":"Travis","year":"2003","journal-title":"Breast Cancer Research"},{"key":"10.1016\/j.bcp.2023.115804_b0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fonc.2017.00110","article-title":"Estrogen effects on the mammary gland in early and late life and breast cancer risk","volume":"7","author":"Dall","year":"2017","journal-title":"Frontiers in Oncology"},{"issue":"11","key":"10.1016\/j.bcp.2023.115804_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112358","article-title":"Estrogen actions in Triple-Negative breast cancer","volume":"9","author":"Treeck","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115804_b0110","doi-asserted-by":"crossref","unstructured":"M. van Barele, B.A.M. Heemskerk-Gerritsen, Y.V. Louwers, M.B. Vastbinder, J.W.M. Martens, M.J. Hooning, A. Jager, Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?, Cancers (Basel) 13(11) (2021).","DOI":"10.3390\/cancers13112506"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41523-022-00472-4","article-title":"High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes","volume":"8","author":"Xu","year":"2022","journal-title":"npj Breast Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0120","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/en.2009-0070","article-title":"Minireview: Obesity and breast cancer: the estrogen connection","volume":"150","author":"Cleary","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2023.115804_b0125","doi-asserted-by":"crossref","unstructured":"K.M. Mair, R. Gaw, M.R. MacLean, Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension, Pulm Circ 10(3) (2020) 2045894020952019.","DOI":"10.1177\/2045894020952023"},{"key":"10.1016\/j.bcp.2023.115804_b0130","doi-asserted-by":"crossref","unstructured":"J. Kerr, C. Anderson, S.M. Lippman, Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence, Lancet Oncol 18(8) (2017) e457-e471.","DOI":"10.1016\/S1470-2045(17)30411-4"},{"key":"10.1016\/j.bcp.2023.115804_b0135","doi-asserted-by":"crossref","unstructured":"A. McTiernan, L. Wu, C. Chen, R. Chlebowski, Y. Mossavar-Rahmani, F. Modugno, M.G. Perri, F.Z. Stanczyk, L. Van Horn, C.Y. Wang, I. Women's Health Initiative, Relation of BMI and physical activity to sex hormones in postmenopausal women, Obesity (Silver Spring) 14(9) (2006) 1662-77.","DOI":"10.1038\/oby.2006.191"},{"key":"10.1016\/j.bcp.2023.115804_b0140","doi-asserted-by":"crossref","unstructured":"X.R. Yang, J. Chang-Claude, E.L. Goode, F.J. Couch, H. Nevanlinna, R.L. Milne, M. Gaudet, M.K. Schmidt, A. Broeks, A. Cox, P.A. Fasching, R. Hein, A.B. Spurdle, F. Blows, K. Driver, D. Flesch-Janys, J. Heinz, P. Sinn, A. Vrieling, T. Heikkinen, K. Aittomaki, P. Heikkila, C. Blomqvist, J. Lissowska, B. Peplonska, S. Chanock, J. Figueroa, L. Brinton, P. Hall, K. Czene, K. Humphreys, H. Darabi, J. Liu, L.J. Van 't Veer, F.E. van Leeuwen, I.L. Andrulis, G. Glendon, J.A. Knight, A.M. Mulligan, F.P. O'Malley, N. Weerasooriya, E.M. John, M.W. Beckmann, A. Hartmann, S.B. Weihbrecht, D.L. Wachter, S.M. Jud, C.R. Loehberg, L. Baglietto, D.R. English, G.G. Giles, C.A. McLean, G. Severi, D. Lambrechts, T. Vandorpe, C. Weltens, R. Paridaens, A. Smeets, P. Neven, H. Wildiers, X. Wang, J.E. Olson, V. Cafourek, Z. Fredericksen, M. Kosel, C. Vachon, H.E. Cramp, D. Connley, S.S. Cross, S.P. Balasubramanian, M.W. Reed, T. Dork, M. Bremer, A. Meyer, J.H. Karstens, A. Ay, T.W. Park-Simon, P. Hillemanns, J.I. Arias Perez, P. Menendez Rodriguez, P. Zamora, J. Benitez, Y.D. Ko, H.P. Fischer, U. Hamann, B. Pesch, T. Bruning, C. Justenhoven, H. Brauch, D.M. Eccles, W.J. Tapper, S.M. Gerty, E.J. Sawyer, I.P. Tomlinson, A. Jones, M. Kerin, N. Miller, N. McInerney, H. Anton-Culver, A. Ziogas, C.Y. Shen, C.N. Hsiung, P.E. Wu, S.L. Yang, J.C. Yu, S.T. Chen, G.C. Hsu, C.A. Haiman, B.E. Henderson, L. Le Marchand, L.N. Kolonel, A. Lindblom, S. Margolin, A. Jakubowska, J. Lubinski, T. Huzarski, T. Byrski, B. Gorski, J. Gronwald, M.J. Hooning, A. Hollestelle, A.M. van den Ouweland, A. Jager, M. Kriege, M.M. Tilanus-Linthorst, M. Collee, S. Wang-Gohrke, K. Pylkas, A. Jukkola-Vuorinen, K. Mononen, M. Grip, P. Hirvikoski, R. Winqvist, A. Mannermaa, V.M. Kosma, J. Kauppinen, V. Kataja, P. Auvinen, Y. Soini, R. Sironen, S.E. Bojesen, D.D. Orsted, D. Kaur-Knudsen, H. Flyger, B.G. Nordestgaard, H. Holland, G. Chenevix-Trench, S. Manoukian, M. Barile, P. Radice, S.E. Hankinson, D.J. Hunter, R. Tamimi, S. Sangrajrang, P. Brennan, J. McKay, F. Odefrey, V. Gaborieau, P. Devilee, P.E. Huijts, R.A. Tollenaar, C. Seynaeve, G.S. Dite, C. Apicella, J.L. Hopper, F. Hammet, H. Tsimiklis, L.D. Smith, M.C. Southey, M.K. Humphreys, D. Easton, P. Pharoah, M.E. Sherman, M. Garcia-Closas, Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies, J Natl Cancer Inst 103(3) (2011) 250-63.","DOI":"10.1093\/jnci\/djq526"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0145","first-page":"611","article-title":"Overweight, obesity, and postmenopausal invasive breast cancer risk: A secondary analysis of the women's health initiative randomized clinical trials, JAMA","volume":"1","author":"Neuhouser","year":"2015","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13058-019-1124-1","article-title":"Updating the role of obesity and cholesterol in breast cancer","volume":"21","author":"Garcia-Estevez","year":"2019","journal-title":"Breast Cancer Research"},{"issue":"10204","key":"10.1016\/j.bcp.2023.115804_b0155","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Collaborative group on hormonal factors in breast, type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","author":"C.","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2023.115804_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.564781","article-title":"Risks, benefits, and treatment modalities of menopausal hormone therapy: Current concepts","volume":"12","author":"Mehta","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.bcp.2023.115804_b0165","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrclinonc.2011.110","article-title":"Hormone replacement therapy and the risk of breast cancer","volume":"8","author":"Narod","year":"2011","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"13","key":"10.1016\/j.bcp.2023.115804_b0170","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's Health initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jech.2008.083774","article-title":"Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries","volume":"66","author":"Zbuk","year":"2012","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0180","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.maturitas.2009.07.015","article-title":"the incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence","volume":"64","author":"Verkooijen","year":"2009","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12940-017-0287-4","article-title":"State of the evidence 2017: an update on the connection between breast cancer and the environment","volume":"16","author":"Gray","year":"2017","journal-title":"Environmental Health"},{"key":"10.1016\/j.bcp.2023.115804_b0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-publhealth-040617-014101","article-title":"Environmental determinants of breast cancer","volume":"39","author":"Hiatt","year":"2018","journal-title":"Annual Review of Public Health"},{"key":"10.1016\/j.bcp.2023.115804_b0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.envres.2017.08.045","article-title":"Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms","volume":"160","author":"Rodgers","year":"2018","journal-title":"Environmental Research"},{"issue":"12","key":"10.1016\/j.bcp.2023.115804_b0200","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1289\/ehp.1408337","article-title":"Screening for chemical contributions to breast cancer risk: A case study for chemical safety evaluation","volume":"123","author":"Schwarzman","year":"2015","journal-title":"Environmental Health Perspectives"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0205","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1038\/s41598-020-62200-x","article-title":"Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in south korea","volume":"10","author":"Hwang","year":"2020","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0890-6238(93)90230-5","article-title":"Estrogenic and antiestrogenic actions of PCBs in the female rat: in vitro and in vivo studies","volume":"7","author":"Jansen","year":"1993","journal-title":"Reproductive Toxicology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0215","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s40471-018-0143-2","article-title":"Air pollution and breast cancer: A review","volume":"5","author":"White","year":"2018","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.bcp.2023.115804_b0220","doi-asserted-by":"crossref","first-page":"1047827","DOI":"10.3389\/fnut.2022.1047827","article-title":"An insight into bisphenol a, food exposure and its adverse effects on health: A review","volume":"9","author":"Manzoor","year":"2022","journal-title":"Frontiers in Nutrition"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0225","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1210\/endo.132.6.8504731","article-title":"Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving","volume":"132","author":"Krishnan","year":"1993","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0230","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1210\/endo.138.5.5132","article-title":"The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo","volume":"138","author":"Steinmetz","year":"1997","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0235","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1507\/endocrj.46.773","article-title":"Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta","volume":"46","author":"Hiroi","year":"1999","journal-title":"Endocrine Journal"},{"issue":"10","key":"10.1016\/j.bcp.2023.115804_b0240","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2023.115804_b0245","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/1471-2407-14-379","article-title":"Cell proliferation and apoptosis in rat mammary glands following combinational exposure to bisphenol A and genistein","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.reprotox.2006.10.002","article-title":"induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure","volume":"23","author":"Murray","year":"2007","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.bcp.2023.115804_b0255","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejca.2017.10.022","article-title":"Mammographic density and breast cancer risk in breast screening assessment cases and women with a family history of breast cancer","volume":"88","author":"Duffy","year":"2018","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0260","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/bcr3432","article-title":"Circulating serum xenoestrogens and mammographic breast density","volume":"15","author":"Sprague","year":"2013","journal-title":"Breast Cancer Research"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3892\/ol.2020.12145","article-title":"Carcinogenic effects of bisphenol A in breast and ovarian cancers","volume":"20","author":"Dumitrascu","year":"2020","journal-title":"Oncology Letters"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19031873","article-title":"Minireview: Parabens exposure and breast cancer","volume":"19","author":"Hager","year":"2022","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.bcp.2023.115804_b0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jpba.2017.12.038","article-title":"Accurate analysis of parabens in human urine using isotope-dilution ultrahigh-performance liquid chromatography-high resolution mass spectrometry","volume":"150","author":"Zhou","year":"2018","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jat.958","article-title":"Concentrations of parabens in human breast tumours","volume":"24","author":"Darbre","year":"2004","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/j.bcp.2023.115804_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.05.084","article-title":"Urinary concentrations of environmental phenols and their associations with breast cancer incidence and mortality following breast cancer","volume":"130","author":"Parada","year":"2019","journal-title":"Environment International"},{"key":"10.1016\/j.bcp.2023.115804_b0290","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.chemosphere.2014.02.082","article-title":"Estrogenic activity of constituents of underarm deodorants determined by e-Screen assay","volume":"108","author":"Lange","year":"2014","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0295","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1734-1140(13)71024-7","article-title":"Effects of single and repeated in vitro exposure of three forms of parabens, methyl-, butyl- and propylparabens on the proliferation and estradiol secretion in MCF-7 and MCF-10A cells","volume":"65","author":"Wrobel","year":"2013","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.bcp.2023.115804_b0300","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.envres.2016.10.021","article-title":"Changes in mammary histology and transcriptome profiles by low-dose exposure to environmental phenols at critical windows of development","volume":"152","author":"Gopalakrishnan","year":"2017","journal-title":"Environmental Research"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/toxics10060278","article-title":"A review of soil contaminated with dioxins and biodegradation technologies: Current status and future prospects","volume":"10","author":"Nhung","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.bcp.2023.115804_b0310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-069X-8-39","article-title":"Cancer incidence in the population exposed to dioxin after the \u201cSeveso accident\u201d: twenty years of follow-up","volume":"8","author":"Pesatori","year":"2009","journal-title":"Environmental Health"},{"issue":"12","key":"10.1016\/j.bcp.2023.115804_b0315","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/oem.2009.052175","article-title":"Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in europe","volume":"67","author":"Villeneuve","year":"2010","journal-title":"Occupational and Environmental Medicine"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0320","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/BF00052430","article-title":"Cancer incidence and mortality in women occupationally exposed to chlorophenoxy herbicides, chlorophenols, and dioxins","volume":"4","author":"Kogevinas","year":"1993","journal-title":"Cancer Causes & Control"},{"key":"10.1016\/j.bcp.2023.115804_b0325","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13058-015-0536-9","article-title":"Estimated dietary dioxin exposure and breast cancer risk among women from the french E3N prospective cohort","volume":"17","author":"Danjou","year":"2015","journal-title":"Breast Cancer Research"},{"issue":"9","key":"10.1016\/j.bcp.2023.115804_b0330","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/carcin\/19.9.1623","article-title":"Prenatal TCDD and predisposition to mammary cancer in the rat","volume":"19","author":"Brown","year":"1998","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.reprotox.2006.10.004","article-title":"Prenatal TCDD exposure predisposes for mammary cancer in rats","volume":"23","author":"Jenkins","year":"2007","journal-title":"Reproductive Toxicology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0340","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1124\/mol.105.019638","article-title":"Dioxin induces an estrogen-like, estrogen receptor-dependent gene expression response in the murine uterus","volume":"69","author":"Boverhof","year":"2006","journal-title":"Molecular Pharmacology"},{"issue":"18","key":"10.1016\/j.bcp.2023.115804_b0345","first-page":"10533","article-title":"Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor","volume":"271","author":"Kharat","year":"1996","journal-title":"Cross-talk between aryl hydrocarbon- and estrogen-mediated signaling, J Biol Chem"},{"key":"10.1016\/j.bcp.2023.115804_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2019.121526","article-title":"in vivo profiling of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced estrogenic\/anti-estrogenic effects in female estrogen-responsive reporter transgenic mice","volume":"385","author":"Yoshida","year":"2020","journal-title":"Journal of Hazardous Materials"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0355","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1289\/ehp.0901047","article-title":"Maternal dioxin exposure combined with a diet high in fat increases mammary cancer incidence in mice","volume":"118","author":"La Merrill","year":"2010","journal-title":"Environmental Health Perspectives"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0360","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/0008-5472.CAN-06-2133","article-title":"Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation","volume":"67","author":"Belous","year":"2007","journal-title":"Cancer Research"},{"issue":"7","key":"10.1016\/j.bcp.2023.115804_b0365","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.metabol.2007.03.001","article-title":"Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA","volume":"56","author":"Zhang","year":"2007","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0370","doi-asserted-by":"crossref","first-page":"e0151598","DOI":"10.1371\/journal.pone.0151598","article-title":"CYP1B1 enhances cell proliferation and metastasis through induction of EMT and activation of Wnt\/beta-Catenin signaling via Sp1 upregulation","volume":"11","author":"Kwon","year":"2016","journal-title":"PLoS One1"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0375","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcb.21630","article-title":"Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue","volume":"104","author":"Yang","year":"2008","journal-title":"Journal of Cellular Biochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0380","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.toxlet.2008.10.026","article-title":"TCDD induces cell migration via NFATc1\/ATX-signaling in MCF-7 cells","volume":"184","author":"Seifert","year":"2009","journal-title":"Toxicology Letters"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0385","first-page":"417","article-title":"TCDD mediates inhibition of p53 and activation of ERalpha signaling in MCF-7 cells at moderate hypoxic conditions","volume":"35","author":"Seifert","year":"2009","journal-title":"International Journal of Oncology"},{"issue":"2\u20133","key":"10.1016\/j.bcp.2023.115804_b0390","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0378-4274(92)90145-A","article-title":"Growth inhibitory and antimitogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells","volume":"61","author":"Fernandez","year":"1992","journal-title":"Toxicology Letters"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0395","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1210\/jc.2009-1140","article-title":"Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method","volume":"95","author":"Courant","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0400","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1210\/clinem\/dgz196","article-title":"Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS\/MS","volume":"105","author":"Frederiksen","year":"2020","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0405","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jpeds.2005.07.016","article-title":"interpreting the continued decline in the average age at menarche: results from two nationally representative surveys of u.S. girls studied 10 years apart","volume":"147","author":"Anderson","year":"2005","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0410","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10552-008-9284-9","article-title":"Socioeconomic status in relation to early menarche among black and white girls","volume":"20","author":"Braithwaite","year":"2009","journal-title":"Cancer Causes & Control"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0415","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13058-020-01326-2","article-title":"Pubertal timing and breast cancer risk in the sister study cohort","volume":"22","author":"Goldberg","year":"2020","journal-title":"Breast Cancer Research"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0420","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/humrep\/dey078","article-title":"The relation of age at menarche with age at natural menopause: a population study of 336 788 women in norway","volume":"33","author":"Bjelland","year":"2018","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0425","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7","article-title":"Association of menstrual and reproductive factors with breast cancer risk: results from the shanghai Breast cancer study","volume":"87","author":"Gao","year":"2000","journal-title":"International Journal of Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2023.115804_b0430","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/ijc.29968","article-title":"Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies","volume":"138","author":"Sisti","year":"2016","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.bcp.2023.115804_b0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/AHMT.S15946","article-title":"Life-course origins of the ages at menarche and menopause","volume":"4","author":"Forman","year":"2013","journal-title":"Adolescent Health, Medicine and Therapeutics"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0440","doi-asserted-by":"crossref","first-page":"hoac005","DOI":"10.1093\/hropen\/hoac005","article-title":"Women's reproductive span: a systematic scoping review","volume":"2022","author":"Nabhan","year":"2022","journal-title":"Hum Reprod Open"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0445","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40169-016-0088-3","article-title":"Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention","volume":"5","author":"Cavalieri","year":"2016","journal-title":"Clinical and Translational Medicine"},{"issue":"18","key":"10.1016\/j.bcp.2023.115804_b0450","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1021\/bi047629p","article-title":"Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers","volume":"44","author":"Felty","year":"2005","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0455","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.freeradbiomed.2009.11.025","article-title":"Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer","volume":"48","author":"Sastre-Serra","year":"2010","journal-title":"Free Radical Biology & Medicine"},{"issue":"8","key":"10.1016\/j.bcp.2023.115804_b0460","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/carcin\/bgr109","article-title":"Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells","volume":"32","author":"Fussell","year":"2011","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.bcp.2023.115804_b0465","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/carcin\/bgs300","article-title":"Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer","volume":"33","author":"Singh","year":"2012","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.bcp.2023.115804_b0470","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1021\/tx970026c","article-title":"Estrogen-nucleic acid adducts: reaction of 3,4-estrone-o-quinone radical anion with deoxyribonucleosides","volume":"10","author":"Akanni","year":"1997","journal-title":"Chemical Research in Toxicology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0475","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1021\/tx960002q","article-title":"Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides","volume":"9","author":"Stack","year":"1996","journal-title":"Chemical Research in Toxicology"},{"issue":"10","key":"10.1016\/j.bcp.2023.115804_b0480","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1158\/0008-5472.CAN-13-2611","article-title":"BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability","volume":"74","author":"Savage","year":"2014","journal-title":"Cancer Research"},{"issue":"1\u20135","key":"10.1016\/j.bcp.2023.115804_b0485","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jsbmb.2006.12.102","article-title":"Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition","volume":"105","author":"Lu","year":"2007","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0490","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1158\/1940-6207.CAPR-08-0037","article-title":"Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells","volume":"1","author":"Lu","year":"2008","journal-title":"Cancer Prevention Research (Philadelphia, Pa.)"},{"issue":"8","key":"10.1016\/j.bcp.2023.115804_b0495","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/ijc.22399","article-title":"Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol","volume":"120","author":"Saeed","year":"2007","journal-title":"International Journal of Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0500","first-page":"423","article-title":"the estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells","volume":"26","author":"Lareef","year":"2005","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.bcp.2023.115804_b0505","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fonc.2014.00106","article-title":"Estrogen signaling and the DNA damage response in hormone dependent breast cancers","volume":"4","author":"Caldon","year":"2014","journal-title":"Frontiers in Oncology"},{"issue":"18","key":"10.1016\/j.bcp.2023.115804_b0510","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1158\/1078-0432.CCR-12-3700","article-title":"Estrogen receptor alpha regulates ATM expression through miRNAs in breast cancer","volume":"19","author":"Guo","year":"2013","journal-title":"Clinical Cancer Research"},{"issue":"14","key":"10.1016\/j.bcp.2023.115804_b0515","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1091\/mbc.e09-01-0085","article-title":"Estrogen inhibits ATR signaling to cell cycle checkpoints and DNA repair","volume":"20","author":"Pedram","year":"2009","journal-title":"Molecular Biology of the Cell"},{"issue":"9","key":"10.1016\/j.bcp.2023.115804_b0520","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1091\/mbc.e09-08-0724","article-title":"Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-alpha","volume":"21","author":"Medunjanin","year":"2010","journal-title":"Molecular Biology of the Cell"},{"issue":"8","key":"10.1016\/j.bcp.2023.115804_b0525","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1158\/0008-5472.CAN-08-3628","article-title":"Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells","volume":"69","author":"Shirley","year":"2009","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0530","first-page":"932","article-title":"Although c-MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER-positive breast cancer","volume":"56","author":"Chen","year":"2020","journal-title":"International Journal of Oncology"},{"key":"10.1016\/j.bcp.2023.115804_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.631007","article-title":"Non-Genomic actions of estrogens on the DNA repair pathways are associated with chemotherapy resistance in breast cancer","volume":"11","author":"Jimenez-Salazar","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"7","key":"10.1016\/j.bcp.2023.115804_b0540","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1128\/MCB.17.7.4059","article-title":"Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution","volume":"17","author":"Planas-Silva","year":"1997","journal-title":"Molecular Cell. Biology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/1414-431x20175612","article-title":"Estrogen and progesterone promote breast cancer cell proliferation by inducing cyclin G1 expression","volume":"51","author":"Tian","year":"2018","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"10.1016\/j.bcp.2023.115804_b0550","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2407-12-29","article-title":"induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells","volume":"12","author":"Yu","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2023.115804_b0555","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsbmb.2017.05.005","article-title":"A role for g-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis","volume":"176","author":"Filardo","year":"2018","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.bcp.2023.115804_b0560","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fendo.2018.00781","article-title":"Estrogen signaling in ERalpha-Negative breast cancer: ERbeta and GPER","volume":"9","author":"Girgert","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0565","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020306","article-title":"G-Protein coupled estrogen receptor in breast cancer","volume":"20","author":"Hsu","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"Pt 3","key":"10.1016\/j.bcp.2023.115804_b0570","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.mce.2015.04.017","article-title":"Estrogen receptor alpha-36 (ER-alpha36): A new player in human breast cancer","volume":"418","author":"Wang","year":"2015","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0575","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3892\/or.2017.5649","article-title":"NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling","volume":"38","author":"Wang","year":"2017","journal-title":"Oncology Reports"},{"key":"10.1016\/j.bcp.2023.115804_b0580","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jsbmb.2014.05.003","article-title":"GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17beta-estradiol in triple-negative breast cancer cells","volume":"143","author":"Yu","year":"2014","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0585","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acs.chemrestox.5b00457","article-title":"Bisphenol A induces migration through a GPER-, FAK-, src-, and ERK2-Dependent pathway in MDA-MB-231 breast cancer cells","volume":"29","author":"Castillo Sanchez","year":"2016","journal-title":"Chemical Research in Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0590","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-019-1056-8","article-title":"Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells","volume":"38","author":"Rigiracciolo","year":"2019","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030622","article-title":"The G Protein-Coupled estrogen receptor (GPER) expression correlates with Pro-Metastatic pathways in ER-Negative breast cancer: A bioinformatics analysis","volume":"9","author":"Talia","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bcp.2023.115804_b0600","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1210\/me.2013-1164","article-title":"Research resource: global identification of estrogen receptor beta target genes in triple negative breast cancer cells","volume":"27","author":"Shanle","year":"2013","journal-title":"Molecular Endocrinology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0605","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tox.2009.09.007","article-title":"AhR and ARNT modulate ER signaling","volume":"268","author":"Swedenborg","year":"2010","journal-title":"Toxicology"},{"issue":"15","key":"10.1016\/j.bcp.2023.115804_b0610","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155264","article-title":"Aryl hydrocarbon receptor connects inflammation to breast cancer","volume":"21","author":"Guarnieri","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.bcp.2023.115804_b0615","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","article-title":"Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals","volume":"43","author":"Denison","year":"2003","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0620","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1074\/jbc.274.6.3430","article-title":"Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells","volume":"274","author":"Ricci","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/j.bcp.2023.115804_b0625","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/ijc.21590","article-title":"Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells","volume":"118","author":"Fernandez","year":"2006","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0630","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/tx050229y","article-title":"the greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity","volume":"19","author":"Zahid","year":"2006","journal-title":"Chemical Research in Toxicology"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0635","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1158\/0008-5472.CAN-16-1717","article-title":"Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women","volume":"77","author":"Sampson","year":"2017","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0640","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.maturitas.2005.08.010","article-title":"Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells","volume":"54","author":"Seeger","year":"2006","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0645","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.chemrestox.6b00256","article-title":"Formation and biological targets of quinones: Cytotoxic versus cytoprotective effects","volume":"30","author":"Bolton","year":"2017","journal-title":"Chemical Research in Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0650","doi-asserted-by":"crossref","first-page":"164","DOI":"10.18632\/oncotarget.10516","article-title":"4-Hydroxyestradiol induces mammary epithelial cell transformation through Nrf2-mediated heme oxygenase-1 overexpression","volume":"8","author":"Park","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0655","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bcp.2008.09.037","article-title":"the role of the aryl hydrocarbon receptor in the female reproductive system","volume":"77","author":"Hernandez-Ochoa","year":"2009","journal-title":"Biochemical Pharmacology"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0660","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1095\/biolreprod.106.057687","article-title":"The aryl hydrocarbon receptor affects mouse ovarian follicle growth via mechanisms involving estradiol regulation and responsiveness","volume":"76","author":"Barnett","year":"2007","journal-title":"Biology of Reproduction"},{"issue":"22","key":"10.1016\/j.bcp.2023.115804_b0665","doi-asserted-by":"crossref","first-page":"21607","DOI":"10.1074\/jbc.C500090200","article-title":"ER alpha-AHR-ARNT protein-protein interactions mediate estradiol-dependent transrepression of dioxin-inducible gene transcription","volume":"280","author":"Beischlag","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"13","key":"10.1016\/j.bcp.2023.115804_b0670","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1128\/MCB.25.13.5317-5328.2005","article-title":"Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters","volume":"25","author":"Matthews","year":"2005","journal-title":"Molecular Cell. Biology"},{"issue":"6939","key":"10.1016\/j.bcp.2023.115804_b0675","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nature01606","article-title":"Modulation of oestrogen receptor signalling by association with the activated dioxin receptor","volume":"423","author":"Ohtake","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0680","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0014-5793(95)01126-Y","article-title":"Expression of cytochrome P450 CYP1B1 in breast cancer","volume":"374","author":"McKay","year":"1995","journal-title":"FEBS Letters"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2023.115804_b0685","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsbmb.2009.06.005","article-title":"Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status","volume":"117","author":"Lonning","year":"2009","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0690","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1006443104670","article-title":"Expression of the aryl hydrocarbon receptor\/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis","volume":"63","author":"Trombino","year":"2000","journal-title":"Breast Cancer Research and Treatment"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0695","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1021\/acs.chemrestox.9b00476","article-title":"the Ah receptor: Adaptive metabolism, ligand diversity, and the xenokine model","volume":"33","author":"Avilla","year":"2020","journal-title":"Chemical Research in Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010387","article-title":"How the AHR became important in cancer: The role of chronically active AHR in Cancer aggression","volume":"22","author":"Wang","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.bcp.2023.115804_b0705","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pestbp.2014.12.021","article-title":"The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells","volume":"120","author":"Bekki","year":"2015","journal-title":"Pesticide Biochemistry and Physiology"},{"issue":"12","key":"10.1016\/j.bcp.2023.115804_b0710","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/ijc.28297","article-title":"Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line","volume":"133","author":"Goode","year":"2013","journal-title":"International Journal of Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0715","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12672-013-0160-z","article-title":"Aryl hydrocarbon receptor in breast cancer-a newly defined prognostic marker","volume":"5","author":"Saito","year":"2014","journal-title":"Horm Cancer"},{"issue":"48","key":"10.1016\/j.bcp.2023.115804_b0720","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1038\/sj.onc.1203945","article-title":"the RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells","volume":"19","author":"Kim","year":"2000","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b0725","article-title":"c-Src and EGFR inhibition in molecular cancer therapy","volume":"12","author":"Belli","year":"2020","journal-title":"What Else Can We Improve?, cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0730","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bcp.2008.09.013","article-title":"Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways","volume":"77","author":"Haarmann-Stemmann","year":"2009","journal-title":"Biochemical Pharmacology"},{"issue":"15","key":"10.1016\/j.bcp.2023.115804_b0735","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1073\/pnas.92.15.6981","article-title":"Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers","volume":"92","author":"Maa","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0740","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/bcr55","article-title":"Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer","volume":"2","author":"Biscardi","year":"2000","journal-title":"Breast Cancer Research"},{"issue":"17","key":"10.1016\/j.bcp.2023.115804_b0745","first-page":"4773","article-title":"Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product","volume":"52","author":"Ottenhoff-Kalff","year":"1992","journal-title":"Cancer Research"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0750","first-page":"383","article-title":"c-Src protein expression is increased in human breast cancer","volume":"180","author":"Verbeek","year":"1996","journal-title":"An immunohistochemical and biochemical analysis, J Pathol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0755","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1078-0432.CCR-04-1749","article-title":"Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression","volume":"12","author":"Diaz","year":"2006","journal-title":"Clinical Cancer Research"},{"issue":"20","key":"10.1016\/j.bcp.2023.115804_b0760","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/sj.onc.1204349","article-title":"Constitutive activation of Stat3 by the src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells","volume":"20","author":"Garcia","year":"2001","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0765","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.toxlet.2009.10.026","article-title":"Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line","volume":"192","author":"Garcia","year":"2010","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.bcp.2023.115804_b0770","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tox.2016.08.007","article-title":"Hexachlorobenzene modulates the crosstalk between the aryl hydrocarbon receptor and transforming growth factor-beta1 signaling, enhancing human breast cancer cell migration and invasion","volume":"366\u2013367","author":"Miret","year":"2016","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2023.115804_b0775","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.toxlet.2017.02.013","article-title":"Hexachlorobenzene alters cell cycle by regulating p27-cyclin E-CDK2 and c-Src-p27 protein complexes","volume":"270","author":"Ventura","year":"2017","journal-title":"Toxicology Letters"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0780","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.taap.2013.02.007","article-title":"Action of hexachlorobenzene on tumor growth and metastasis in different experimental models","volume":"268","author":"Pontillo","year":"2013","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.bcp.2023.115804_b0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2015.10.010","article-title":"Pesticide chlorpyrifos acts as an endocrine disruptor in adult rats causing changes in mammary gland and hormonal balance","volume":"156","author":"Ventura","year":"2016","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"Pt A","key":"10.1016\/j.bcp.2023.115804_b0790","article-title":"Endocrine disruptor chlorpyrifos promotes migration, invasion, and stemness phenotype in 3D cultures of breast cancer cells and induces a wide range of pathways involved in cancer progression","volume":"204","author":"Lasagna","year":"2022","journal-title":"Environmental Research"},{"key":"10.1016\/j.bcp.2023.115804_b0795","doi-asserted-by":"crossref","first-page":"1095289","DOI":"10.3389\/fphar.2022.1095289","article-title":"Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer","volume":"13","author":"Sweeney","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/j.bcp.2023.115804_b0800","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/jcb.30275","article-title":"Extracellular acidosis stimulates breast cancer cell motility through aryl hydrocarbon receptor and c-src kinase activation","volume":"123","author":"Miret","year":"2022","journal-title":"Journal of Cellular Biochemistry"},{"issue":"10","key":"10.1016\/j.bcp.2023.115804_b0805","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.115.064246","article-title":"Indole and tryptophan metabolism: Endogenous and dietary routes to ah receptor activation","volume":"43","author":"Hubbard","year":"2015","journal-title":"Drug Metabolism and Disposition"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0810","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0021-9258(19)50967-X","article-title":"the conversion of tryptophan to kynurenine in liver. I. the coupled tryptophan peroxidase-oxidase system forming formylkynurenine","volume":"187","author":"Knox","year":"1950","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0815","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/2326-6066.CIR-14-0137","article-title":"Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues","volume":"3","author":"Theate","year":"2015","journal-title":"Cancer Immunology Research"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0820","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00262-013-1393-y","article-title":"Analysis of indoleamine 2\u20133 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry","volume":"62","author":"Soliman","year":"2013","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"21","key":"10.1016\/j.bcp.2023.115804_b0825","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/0008-5472.CAN-15-2011","article-title":"A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer","volume":"75","author":"D'Amato","year":"2015","journal-title":"Cancer Research"},{"issue":"22","key":"10.1016\/j.bcp.2023.115804_b0830","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228705","article-title":"Developmental programming and reprogramming of hypertension and kidney disease: Impact of tryptophan metabolism","volume":"21","author":"Hsu","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0835","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tips.2020.11.006","article-title":"Tryptophan metabolism as a pharmacological target","volume":"42","author":"Modoux","year":"2021","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0840","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2125.1978.tb01630.x","article-title":"Metabolism of an oral tryptophan load by women and evidence against the induction of tryptophan pyrrolase by oral contraceptives","volume":"5","author":"Green","year":"1978","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0845","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0026-0495(73)90267-9","article-title":"Urinary excretion of quinolinic acid and other tryptophan metabolites after deoxypyridoxine or oral contraceptive administration","volume":"22","author":"Rose","year":"1973","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0850","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0009-8981(67)90161-1","article-title":"The influence of sex, age and breast cancer on tryptophan metabolism","volume":"18","author":"Rose","year":"1967","journal-title":"Clinica Chimica Acta"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0855","doi-asserted-by":"crossref","first-page":"17559","DOI":"10.1038\/s41598-017-17979-7","article-title":"Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives","volume":"7","author":"Jayawickrama","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0860","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1749-6632.1969.tb54267.x","article-title":"Effects of steroid and nonsteroid metabolites on enzyme conformation and pyridoxal phosphate binding","volume":"166","author":"Mason","year":"1969","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.bcp.2023.115804_b0865","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0021-9258(18)69404-9","article-title":"Estrogen-enzyme interactions: Inhibition and protection of kynurenine transaminase by the sulfate esters of diethylstilbestrol, estradiol, and estrone","volume":"235","author":"Mason","year":"1960","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0870","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0304-4165(69)90045-2","article-title":"the influence of sex and estrogens on liver kynureninase and kynurenine aminotransferase in the rat","volume":"184","author":"Rose","year":"1969","journal-title":"Biochimica et Biophysica Acta, Lipids and Lipid Metabolism"},{"key":"10.1016\/j.bcp.2023.115804_b0875","unstructured":"T. Yatsuhashi, The Activities of Some Enzymes of Tryptophan Metabolism in Fetal, Neonatal and Adult Rat Liver and Kidney. Ii. Kynurenine 3-Hydroxylase Activity, Nagoya J Med Sci 27 (1965) 223-7."},{"key":"10.1016\/j.bcp.2023.115804_b0880","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1756-0500-4-156","article-title":"Tryptophan degradation in women with breast cancer: a pilot study","volume":"4","author":"Lyon","year":"2011","journal-title":"BMC Research Notes"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0885","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-019-1984-2","article-title":"Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy","volume":"17","author":"Onesti","year":"2019","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0890","doi-asserted-by":"crossref","first-page":"e13197","DOI":"10.1111\/aji.13197","article-title":"Estrogen induces indoleamine 2,3-dioxygenase expression via suppressors of cytokine signaling 3 in the chorionic villi and decidua of women in early pregnancy","volume":"83","author":"Li","year":"2020","journal-title":"American Journal of Reproductive Immunology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0895","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbrc.2005.07.057","article-title":"Estrogen receptor-alpha regulates SOCS-3 expression in human breast cancer cells","volume":"335","author":"Matthews","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0900","first-page":"33","article-title":"Decreased expression of SOCS-3 mRNA in breast cancer with lymph node metastasis","volume":"19","author":"Nakagawa","year":"2008","journal-title":"Oncology Reports"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0905","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s12885-021-08434-y","article-title":"Comprehensive analysis of suppressor of cytokine signaling proteins in human breast cancer","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.bcp.2023.115804_b0910","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrc3846","article-title":"Aryl hydrocarbon receptor ligands in cancer: friend and foe","volume":"14","author":"Murray","year":"2014","journal-title":"Nature Reviews. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0915","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/cei.12352","article-title":"activation of the aryl hydrocarbon receptor affects activation and function of human monocyte-derived dendritic cells","volume":"177","author":"Wang","year":"2014","journal-title":"Clinical and Experimental Immunology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0920","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1124\/mol.116.105361","article-title":"An aryl hydrocarbon Receptor-Mediated amplification loop that enforces cell migration in ER-\/PR-\/Her2- human breast cancer cells","volume":"90","author":"Novikov","year":"2016","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0925","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13058-020-01351-1","article-title":"Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression","volume":"22","author":"Heng","year":"2020","journal-title":"Breast Cancer Research"},{"key":"10.1016\/j.bcp.2023.115804_b0930","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.omto.2020.03.013","article-title":"Comprehensive analysis of the expression and prognosis for TDO2 in breast cancer","volume":"17","author":"Liu","year":"2020","journal-title":"Molecular Therapy - Oncolytics"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0935","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","article-title":"Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling","volume":"115","author":"DiNatale","year":"2010","journal-title":"Toxicological Sciences"},{"issue":"10","key":"10.1016\/j.bcp.2023.115804_b0940","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41379-018-0061-3","article-title":"IDO expression in breast cancer: an assessment of 281 primary and metastatic cases with comparison to PD-L1","volume":"31","author":"Dill","year":"2018","journal-title":"Modern Pathology"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b0945","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2567.2002.01526.x","article-title":"tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division","volume":"107","author":"Lee","year":"2002","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b0950","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in t cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.bcp.2023.115804_b0955","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood-2006-07-036863","article-title":"Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells","volume":"109","author":"Curti","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0960","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1158\/1541-7786.MCR-18-0362","article-title":"A role for tryptophan-2,3-dioxygenase in CD8 t-cell suppression and evidence of tryptophan catabolism in breast cancer patient plasma","volume":"17","author":"Greene","year":"2019","journal-title":"Molecular Cancer Research"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0965","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13058-015-0632-x","article-title":"Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study","volume":"17","author":"Miyashita","year":"2015","journal-title":"Breast Cancer Research"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b0970","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jcp.21221","article-title":"Induction of regulatory T cells by physiological level estrogen","volume":"214","author":"Tai","year":"2008","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0975","doi-asserted-by":"crossref","first-page":"17289","DOI":"10.1038\/s41598-017-17102-w","article-title":"Oestrogen receptor-alpha binds the FOXP3 promoter and modulates regulatory t-cell function in human cervical cancer","volume":"7","author":"Adurthi","year":"2017","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b0980","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2567.2006.02339.x","article-title":"Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation","volume":"118","author":"Prieto","year":"2006","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b0985","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1158\/0008-5472.CAN-20-1200","article-title":"Steroid hormone receptor and infiltrating immune cell status reveals therapeutic vulnerabilities of ESR1-Mutant breast cancer","volume":"81","author":"Williams","year":"2021","journal-title":"Cancer Research"},{"key":"10.1016\/j.bcp.2023.115804_b0990","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.intimp.2016.03.009","article-title":"CD4+CD25+ regulatory T cells in tumor immunity","volume":"34","author":"Chen","year":"2016","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.bcp.2023.115804_b0995","doi-asserted-by":"crossref","unstructured":"L.F. Ambrosio, C. Insfran, X. Volpini, E. Acosta Rodriguez, H.M. Serra, F.J. Quintana, L. Cervi, C.C. Motran, Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During Trypanosoma cruzi Infection, Front Immunol 10 (2019) 631.","DOI":"10.3389\/fimmu.2019.00631"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b1000","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the IDO1\/TDO2-KYN-AhR pathway for cancer immunotherapy - challenges and opportunities","volume":"39","author":"Cheong","year":"2018","journal-title":"Trends in Pharmacological Sciences"},{"issue":"9","key":"10.1016\/j.bcp.2023.115804_b1005","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ni.1912","article-title":"the aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27","volume":"11","author":"Apetoh","year":"2010","journal-title":"Nature Immunology"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b1010","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.abb.2011.05.011","article-title":"interaction of aryl hydrocarbon receptor and NF-kappaB subunit RelB in breast cancer is associated with interleukin-8 overexpression","volume":"512","author":"Vogel","year":"2011","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b1020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bcp.2008.09.036","article-title":"A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family","volume":"77","author":"Vogel","year":"2009","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"8","key":"10.1016\/j.bcp.2023.115804_b1030","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/ijc.21562","article-title":"Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer","volume":"118","author":"Irahara","year":"2006","journal-title":"International Journal of Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ijc.28679","article-title":"Activation of a positive feedback loop involving IL-6 and aromatase promotes intratumoral 17beta-estradiol biosynthesis in endometrial carcinoma microenvironment","volume":"135","author":"Che","year":"2014","journal-title":"International Journal of Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tranon.2017.12.009","article-title":"Multifaceted roles of interleukin-6 in Adipocyte-Breast cancer cell interaction","volume":"11","author":"Gyamfi","year":"2018","journal-title":"Translational Oncology"},{"issue":"11","key":"10.1016\/j.bcp.2023.115804_b1045","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of STAT3 in breast cancer cells: A review","volume":"138","author":"Banerjee","year":"2016","journal-title":"International Journal of Cancer"},{"key":"10.1016\/j.bcp.2023.115804_b1050","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.866014","article-title":"IL-6\/JAK\/STAT3 signaling in breast cancer metastasis: Biology and treatment","volume":"12","author":"Manore","year":"2022","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/jir.2005.25.20","article-title":"the role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase","volume":"25","author":"Robinson","year":"2005","journal-title":"Journal of Interferon & Cytokine Research"},{"issue":"11","key":"10.1016\/j.bcp.2023.115804_b1060","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.bjc.6600956","article-title":"Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients","volume":"88","author":"Bachelot","year":"2003","journal-title":"British Journal of Cancer"},{"key":"10.1016\/j.bcp.2023.115804_b1065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12957-015-0529-2","article-title":"interleukin-6 and pro inflammatory status in the breast tumor microenvironment","volume":"13","author":"Sanguinetti","year":"2015","journal-title":"World Journal of Surgical Oncology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","article-title":"Konwar, role of interleukin-10 in breast cancer","volume":"133","author":"Hamidullah","year":"2012","journal-title":"Breast Cancer Research and Treatment"},{"issue":"4","key":"10.1016\/j.bcp.2023.115804_b1075","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.4049\/jimmunol.1300497","article-title":"The aryl hydrocarbon receptor promotes IL-10 production by NK cells","volume":"192","author":"Wagage","year":"2014","journal-title":"Journal of Immunology"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b1080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051016","article-title":"the prognostic impact of the aryl hydrocarbon receptor (AhR) in primary breast cancer depends on the lymph node status","volume":"20","author":"Jeschke","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.bcp.2023.115804_b1085","article-title":"the prognostic impact of intratumoral aryl hydrocarbon receptor in primary breast cancer depends on the type of endocrine therapy: A Population-Based cohort study, front","volume":"11","author":"Tryggvadottir","year":"2021","journal-title":"Oncol"},{"issue":"22","key":"10.1016\/j.bcp.2023.115804_b1090","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1042\/BCJ20170728","article-title":"Carbidopa: a selective ah receptor modulator (SAhRM)","volume":"474","author":"Safe","year":"2017","journal-title":"Biochemistry Journal"},{"issue":"20","key":"10.1016\/j.bcp.2023.115804_b1095","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1042\/BCJ20170583","article-title":"Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy","volume":"474","author":"Ogura","year":"2017","journal-title":"Biochemistry Journal"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b1100","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/s10637-022-01289-5","article-title":"Carbidopa suppresses estrogen receptor-positive breast cancer via AhR-mediated proteasomal degradation of ERalpha","volume":"40","author":"Chen","year":"2022","journal-title":"Investigational New Drugs"},{"issue":"9","key":"10.1016\/j.bcp.2023.115804_b1105","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090409","article-title":"Carbidopa alters tryptophan metabolism in breast cancer and melanoma cells leading to the formation of Indole-3-Acetonitrile, a Pro-Proliferative metabolite","volume":"9","author":"Duarte","year":"2019","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b1110","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/med.21645","article-title":"The aryl hydrocarbon receptor (AhR) as a breast cancer drug target","volume":"40","author":"Baker","year":"2020","journal-title":"Medicinal Research Reviews"},{"issue":"7","key":"10.1016\/j.bcp.2023.115804_b1115","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00204-017-1981-2","article-title":"Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target","volume":"91","author":"Kolluri","year":"2017","journal-title":"Archives of Toxicology"},{"issue":"18","key":"10.1016\/j.bcp.2023.115804_b1120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186654","article-title":"Aryl hydrocarbon receptor (AHR) ligands as selective AHR modulators (SAhRMs)","volume":"21","author":"Safe","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/toxsci\/kfr247","article-title":"Activation of the aryl hydrocarbon receptor by TCDD inhibits mammary tumor metastasis in a syngeneic mouse model of breast cancer","volume":"124","author":"Wang","year":"2011","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.bcp.2023.115804_b1130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12935-020-01568-2","article-title":"SOX4 promotes the growth and metastasis of breast cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell International"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/1535-7163.MCT-11-0548","article-title":"Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells","volume":"11","author":"Zhang","year":"2012","journal-title":"Molecular Cancer Therapeutics"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b1140","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1677\/ERC-09-0054","article-title":"The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy","volume":"16","author":"Zhang","year":"2009","journal-title":"Endocrine-Related Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2023.115804_b1145","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1158\/0008-5472.CAN-03-1770","article-title":"Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alpha","volume":"64","author":"Pearce","year":"2004","journal-title":"Cancer Research"},{"issue":"12","key":"10.1016\/j.bcp.2023.115804_b1150","doi-asserted-by":"crossref","first-page":"e0167650","DOI":"10.1371\/journal.pone.0167650","article-title":"Novel aryl hydrocarbon receptor agonist suppresses migration and invasion of breast cancer cells","volume":"11","author":"Hanieh","year":"2016","journal-title":"PLoS One1"},{"issue":"6","key":"10.1016\/j.bcp.2023.115804_b1155","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1158\/1535-7163.715.3.6","article-title":"Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells","volume":"3","author":"Loaiza-Perez","year":"2004","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/j.bcp.2023.115804_b1160","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/1471-2407-14-344","article-title":"Estrogen receptor alpha and aryl hydrocarbon receptor independent growth inhibitory effects of aminoflavone in breast cancer cells","volume":"14","author":"Brinkman","year":"2014","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b1165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/bjc.1998.122","article-title":"2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity","volume":"77","author":"Bradshaw","year":"1998","journal-title":"British Journal of Cancer"},{"issue":"17","key":"10.1016\/j.bcp.2023.115804_b1170","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1021\/jm9600959","article-title":"Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo","volume":"39","author":"Shi","year":"1996","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/mol.61.1.13","article-title":"Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole","volume":"61","author":"Loaiza-Perez","year":"2002","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/B:BREA.0000041586.64371.88","article-title":"The experimental antitumor agents phortress and doxorubicin are equiactive against human-derived breast carcinoma xenograft models","volume":"87","author":"Fichtner","year":"2004","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/j.bcp.2023.115804_b1185","unstructured":"M.C. Seckl, Nicola, A. Boddy, R. Phillips, F. Chapman, P. Schmid, H. Calvert, L. Robson, R. Plummer, A Cancer Research UK Phase I Trial of Phortress (Novel Antitumour Benzothiazole) Given Intravenously in Consecutive 21 Day Cycles with Treatment on Day 1 of Each Cycle, 2012. https:\/\/abstracts.ncri.org.uk\/abstract\/a-cancer-research-uk-phase-i-trial-of-phortress-novel-antitumour-benzothiazole-given-intravenously-in-consecutive-21-day-cycles-with-treatment-on-day-1-of-each-cycle-2\/. (Accessed 01\/08\/2023 2023)."},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1190","doi-asserted-by":"crossref","first-page":"e88726","DOI":"10.1371\/journal.pone.0088726","article-title":"Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent tregs and prevent murine graft-versus-host disease","volume":"9","author":"Punj","year":"2014","journal-title":"PLoS One1"},{"issue":"9","key":"10.1016\/j.bcp.2023.115804_b1195","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/cmdc.202000721","article-title":"Modelling and phenotypic screening of NAP-6 and 10-Cl-BBQ, AhR ligands displaying selective breast cancer cytotoxicity in vitro","volume":"16","author":"Baker","year":"2021","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1200","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1038\/cddis.2013.549","article-title":"The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells","volume":"5","author":"O'Donnell","year":"2014","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.bcp.2023.115804_b1205","doi-asserted-by":"crossref","unstructured":"V.G. Vogel, J.P. Costantino, D.L. Wickerham, W.M. Cronin, R.S. Cecchini, J.N. Atkins, T.B. Bevers, L. Fehrenbacher, E.R. Pajon, Jr., J.L. Wade, 3rd, A. Robidoux, R.G. Margolese, J. James, S.M. Lippman, C.D. Runowicz, P.A. Ganz, S.E. Reis, W. McCaskill-Stevens, L.G. Ford, V.C. Jordan, N. Wolmark, B. National Surgical Adjuvant, P. Bowel, Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial, JAMA 295(23) (2006) 2727-41.","DOI":"10.1097\/01.ogx.0000238648.23538.42"},{"key":"10.1016\/j.bcp.2023.115804_b1210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/1471-2407-14-498","article-title":"The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis","volume":"14","author":"Jin","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bcp.2023.115804_b1215","doi-asserted-by":"crossref","unstructured":"B. McClellan, T. Pham, B. Harlow, G. Lee, D. Quach, C. Jolly, A. Brenner, L. deGraffenried, Modulation of Breast Cancer Cell FASN Expression by Obesity-Related Systemic Factors, Breast Cancer (Auckl) 16 (2022) 11782234221111374.","DOI":"10.1177\/11782234221111374"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1220","first-page":"27","article-title":"fatty acid synthase promotes breast cancer metastasis by mediating changes in fatty acid metabolism","volume":"21","author":"Xu","year":"2021","journal-title":"Oncology Letters"},{"issue":"21","key":"10.1016\/j.bcp.2023.115804_b1225","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1158\/1078-0432.CCR-21-0493","article-title":"inhibiting fatty acid synthase with omeprazole to improve efficacy of neoadjuvant chemotherapy in patients with operable TNBC","volume":"27","author":"Sardesai","year":"2021","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11764-019-00815-4","article-title":"Cognitive problems of breast cancer survivors on proton pump inhibitors","volume":"14","author":"Madison","year":"2020","journal-title":"Journal of Cancer Survivorship"},{"issue":"32","key":"10.1016\/j.bcp.2023.115804_b1235","doi-asserted-by":"crossref","first-page":"22972","DOI":"10.1074\/jbc.M113.475624","article-title":"Activation of aryl hydrocarbon receptor (ahr) by tranilast, an anti-allergy drug, promotes miR-302 expression and cell reprogramming","volume":"288","author":"Hu","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b1240","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/CAD.0b013e328327994e","article-title":"Tranilast inhibits the growth and metastasis of mammary carcinoma","volume":"20","author":"Chakrabarti","year":"2009","journal-title":"Anti-Cancer Drugs"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1245","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yexmp.2010.10.012","article-title":"Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells","volume":"90","author":"Subramaniam","year":"2011","journal-title":"Experimental and Molecular Pathology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1250","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1423-0127-20-76","article-title":"Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro","volume":"20","author":"Darakhshan","year":"2013","journal-title":"Journal of Biomedical Science"},{"issue":"8","key":"10.1016\/j.bcp.2023.115804_b1255","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/carcin\/bgi359","article-title":"Sulindac regulates the aryl hydrocarbon receptor-mediated expression of phase 1 metabolic enzymes in vivo and in vitro","volume":"27","author":"Ciolino","year":"2006","journal-title":"Carcinogenesis"},{"issue":"5","key":"10.1016\/j.bcp.2023.115804_b1260","first-page":"7981","article-title":"Effects of sulindac sulfide on proliferation and apoptosis of human breast cancer cell","volume":"15","author":"Sui","year":"2018","journal-title":"Oncology Letters"},{"key":"10.1016\/j.bcp.2023.115804_b1265","doi-asserted-by":"crossref","first-page":"19534","DOI":"10.1038\/srep19534","article-title":"Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator","volume":"6","author":"Yin","year":"2016","journal-title":"Scientific Reports"},{"issue":"20","key":"10.1016\/j.bcp.2023.115804_b1270","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1158\/1078-0432.CCR-21-0732","article-title":"Sulindac, a nonselective NSAID, reduces breast density in postmenopausal women with breast cancer treated with aromatase inhibitors","volume":"27","author":"Thompson","year":"2021","journal-title":"Clinical Cancer Research"},{"issue":"7","key":"10.1016\/j.bcp.2023.115804_b1275","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10408444.2018.1493086","article-title":"The tryptophan derivative 6-formylindolo[3,2-b]carbazole, FICZ, a dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth and differentiation","volume":"48","author":"Rannug","year":"2018","journal-title":"Critical Reviews in Toxicology"},{"issue":"30","key":"10.1016\/j.bcp.2023.115804_b1280","doi-asserted-by":"crossref","first-page":"12391","DOI":"10.1073\/pnas.1302856110","article-title":"Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor","volume":"110","author":"Shin","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000527993","article-title":"The aryl hydrocarbon receptor ligand 6-Formylindolo(3,2-b)carbazole promotes estrogen receptor alpha and c-Fos protein degradation and inhibits MCF-7 cell proliferation and migration","volume":"108","author":"Cano-Sanchez","year":"2023","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2023.115804_b1290","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1038\/ncomms8209","article-title":"Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells","volume":"6","author":"Cheng","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/j.bcp.2023.115804_b1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113845","article-title":"The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells","volume":"174","author":"Piwarski","year":"2020","journal-title":"Biochemical Pharmacology"},{"issue":"23","key":"10.1016\/j.bcp.2023.115804_b1300","doi-asserted-by":"crossref","first-page":"14694","DOI":"10.1073\/pnas.232562899","article-title":"A ligand for the aryl hydrocarbon receptor isolated from lung","volume":"99","author":"Song","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"0.25","key":"10.1016\/j.bcp.2023.115804_b1305","article-title":"Indoximod modulates AhR-driven transcription of genes that control immune function","volume":"1","author":"Brincks","year":"2018","journal-title":"Ratio"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b1310","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nm1196","article-title":"Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy","volume":"11","author":"Muller","year":"2005","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1315","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jamaoncol.2020.5572","article-title":"Effect of taxane chemotherapy with or without indoximod in metastatic breast cancer: A randomized clinical trial","volume":"7","author":"Mariotti","year":"2021","journal-title":"JAMA Oncology"},{"key":"10.1016\/j.bcp.2023.115804_b1320","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fonc.2018.00423","article-title":"Updates in the clinical development of epacadostat and other indoleamine 2,3-Dioxygenase 1 inhibitors (IDO1) for human cancers","volume":"8","author":"Komiya","year":"2018","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.bcp.2023.115804_b1325","doi-asserted-by":"crossref","unstructured":"A.I. Spira, O. Hamid, T.M. Bauer, V.F. Borges, J.S. Wasser, D.C. Smith, A. Sanders Clark, E.V. Schmidt, Y. Zhao, J.E. Maleski, T.C. Gangadhar, Efficacy\/safety of epacadostat plus pembrolizumab in triple-negative breast cancer and ovarian cancer: Phase I\/II ECHO-202 study, Journal of Clinical Oncology 35(15_suppl) (2017) 1103-1103.","DOI":"10.1200\/JCO.2017.35.15_suppl.1103"},{"key":"10.1016\/j.bcp.2023.115804_b1330","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.taap.2017.03.012","article-title":"Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor","volume":"323","author":"Moyer","year":"2017","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"British Journal of Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2023.115804_b1340","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40425-018-0351-9","article-title":"Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors","volume":"6","author":"Nayak-Kapoor","year":"2018","journal-title":"Journal for Immunotherapy of Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1345","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s10637-019-00787-3","article-title":"Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in japanese patients with advanced solid tumours","volume":"38","author":"Ebata","year":"2020","journal-title":"Investigational New Drugs"},{"issue":"11","key":"10.1016\/j.bcp.2023.115804_b1350","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1158\/1078-0432.CCR-18-2740","article-title":"Phase I study of the indoleamine 2,3-Dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (Atezolizumab) in advanced solid tumors","volume":"25","author":"Jung","year":"2019","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1355","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.abb.2008.01.014","article-title":"The mouse and human ah receptor differ in recognition of LXXLL motifs","volume":"471","author":"Flaveny","year":"2008","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"2","key":"10.1016\/j.bcp.2023.115804_b1360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/toxsci\/kfp308","article-title":"Differential gene regulation by the human and mouse aryl hydrocarbon receptor","volume":"114","author":"Flaveny","year":"2010","journal-title":"Toxicological Sciences"},{"issue":"3","key":"10.1016\/j.bcp.2023.115804_b1365","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4255\/mcpharmacol.09.15","article-title":"Transgenic humanized AHR mouse reveals differences between Human and mouse AHR ligand selectivity","volume":"1","author":"Flaveny","year":"2009","journal-title":"Molecular and Cellular Pharmacology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223003957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223003957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:35:52Z","timestamp":1736346952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223003957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":273,"alternative-id":["S0006295223003957"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115804","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115804"}}